-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Keyuan News
02
2025-06
Recently, Keyuan Pharmaceutical held a special marketing work conference. Chairman and President Gao Chunpo, along with the management team and core members of the sales team, attended the meeting in full force. The discussion centered on accelerating target achievement, strengthening cost control to boost efficiency, and strategically positioning new products for breakthroughs. Focusing on these three key areas, the meeting laid out priorities for the next phase, emphasizing a determined, multi-pronged approach to fully commit to meeting and exceeding the company’s targets.
2025-06-02
21
2025-05
On the 21st, the 92nd China International Pharmaceutical Raw Materials/Materials/Packaging/Equipment Fair (API China) kicked off with great fanfare at the China Import and Export Fair Complex in Guangzhou, bringing together pharmaceutical companies from around the globe in the "Flower City." As a leading enterprise in China's specialized chemical raw materials sector, Keyuan Pharmaceutical (stock code: 3012851.SZ) was invited to showcase its range of core products and groundbreaking technological advancements, highlighting its robust capabilities in raw material R&D, manufacturing, and global expansion. The company’s presence drew extensive attention from industry experts, strategic partners, and media representatives alike.
2025-05-21
13
2025-05
To deeply implement the company’s “Talent-Driven Enterprise” strategy and enhance its core competitiveness, Keyuan Pharmaceutical (stock code: 301281.SZ) successfully held a special training session on patents and lean management on the 13th. Renowned intellectual property experts were invited as instructors to deliver on-site lectures, injecting new momentum into the company’s innovative development and refined management practices.
2025-05-13
30
2025-04
To continuously advance the development of a learning-oriented team and enhance the quality management capabilities of all employees, Keyuan Pharmaceutical (stock code: 301281.SZ) organized a specialized training session on quality management from April 28 to 29. The event aimed to strengthen employees' sense of quality responsibility through systematic learning, thereby solidifying the foundation for the company's high-quality growth.
2025-04-30
24
2025-04
To thoroughly implement the primary responsibility of enterprises for safe production and strengthen the effectiveness of safety and environmental management, Keyuan Pharmaceutical held its quarterly safety production meeting for the first quarter of 2025 on April 23rd. Leaders in charge from various company departments and members of the Safety Committee attended the meeting, systematically reviewing the achievements made in safety and environmental protection during the first quarter, drawing valuable lessons from these experiences, and outlining key tasks for the second quarter—laying a solid foundation for maintaining a stable and positive safety production outlook throughout the year.
2025-04-24
20
2025-04
Today is Guyu—when rain nurtures all grains, and everything thrives in perfect harmony with the season. Truly, April is the most enchanting time of year; let’s cherish this vibrant spring and live up to both nature’s beauty and our own potential!
2025-04-20
15
2025-04
To accelerate its global expansion and deepen its outreach into international markets, recently, Keyuan Pharmaceutical (stock code: 301281.SZ) showcased its flagship products and innovative solutions at two prestigious international trade shows—CPhI Japan, the Japan International Pharmaceutical Ingredients Exhibition, and in-cosmetics Global in the Netherlands, Europe's leading event for cosmetic raw materials. Through these platforms, the company highlighted its cutting-edge expertise in both pharmaceutical and cosmetic ingredient fields, further fostering global collaboration and driving the efficient integration of industry resources.
2025-04-15
23
2025-03
To celebrate World Book Day and foster the integration of learning with practical application, thereby further enhancing the overall quality and professional capabilities of all employees, Keyuan Grand Lecture Hall is specially launching the "Read One Book Together" guided reading activity on April 23. This initiative leverages the power of reading to drive personal growth, helping build a learning-oriented team committed to continuous, lifelong learning—and ultimately strengthening the company's intrinsic soft power.
2025-03-23
23
2025-03
Keyuan Pharmaceutical Wins the "2025 Forbes China Industry Development Innovation Brand Award"!
On March 22, the "2025 Forbes China Industry Development Leader Selection" was held in Shanghai. Shandong Keyuan Pharmaceutical Co., Ltd. (hereinafter referred to as "Keyuan Pharmaceutical"; stock code: 301281.SZ) was honored with the 2025 Forbes China Industry Development Innovation Brand Award, thanks to its outstanding innovation capabilities and significant industry influence. This prestigious award not only recognizes Keyuan Pharmaceutical's years of dedicated efforts in the chemical API and formulation sectors but also serves as a powerful testament to the company's ability to achieve transformative growth through innovation amid the ongoing global industrial restructuring.
2025-03-23
23
2025-03
On the 22nd, Keyuan Pharmaceutical successfully held its Q1 2025 Marketing Conference, themed "Embrace Productism, Focus on Precision Cultivation, Deeply Unlock Potential, Foster Systemic Collaboration, and Deliver Targeted Empowerment—Uniting All Employees to Drive Marketing Targets Toward Breakthrough Success." The meeting provided a comprehensive review of the company's Q1 marketing achievements and outlined the sales objectives for the second quarter. Senior company leaders, the sales team, and heads of various functional departments gathered together to collaboratively explore strategies for achieving and surpassing this year's marketing targets.
2025-03-23
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline